These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 27779207

  • 1. HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression.
    Chen L, Gu L, Gu Y, Wang H, Deng M, Stamataki Z, Oo YH, Huang Y.
    Sci Rep; 2016 Oct 25; 6():35917. PubMed ID: 27779207
    [Abstract] [Full Text] [Related]

  • 2. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription.
    Huang Y, Tai AW, Tong S, Lok AS.
    J Hepatol; 2013 Jun 25; 58(6):1068-73. PubMed ID: 23348237
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
    Yan J, Yao Z, Hu K, Zhong Y, Li M, Xiong Z, Deng M.
    Dig Dis Sci; 2015 May 25; 60(5):1315-24. PubMed ID: 25567052
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z, Zhuang L, Lu Y, Xu Q, Tang B, Chen X.
    Oncotarget; 2016 Mar 15; 7(11):12525-36. PubMed ID: 26848866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R, Surdo M, Cortese MF, Palumbo GA, Carioti L, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Pasquazzi C, Mirabelli C, Scutari R, Sacco A, Alkhatib M, Missale G, Francioso S, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Levrero M, Perno CF, Belloni L, Svicher V.
    Clin Microbiol Infect; 2019 Jul 15; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [Abstract] [Full Text] [Related]

  • 9. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q, Ji XW, Hou XM, Lu FM, Du Y, Yin JH, Sun XY, Deng Y, Zhao J, Han X, Yang GS, Zhang HW, Chen XM, Shen HB, Wang HY, Cao GW.
    Ann Oncol; 2014 Dec 15; 25(12):2413-2419. PubMed ID: 25223483
    [Abstract] [Full Text] [Related]

  • 10. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
    Tan YW, Zhang YH, Jiang WJ, Xing MY, Man XB, Mao JZ, Ge GH, Wu CS, Zhu MQ, Xu J, Sun L, Zhou XP.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep 15; 21(9):679-83. PubMed ID: 24160343
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
    Li GJ, Harrison TJ, Yang JY, Chen QY, Wang XY, Fang ZL.
    Liver Int; 2013 Jul 15; 33(6):936-43. PubMed ID: 23517325
    [Abstract] [Full Text] [Related]

  • 14. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
    Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL.
    Gut; 2008 Jan 15; 57(1):98-102. PubMed ID: 17483190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.
    Puche ML, Kay-Valero S, Michelli P, Oropeza MD, Loureiro CL, Devesa M, Dagher L, Pujol FH.
    Invest Clin; 2016 Mar 15; 57(1):38-46. PubMed ID: 27382800
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Relationship between hepatitis B virus genotype, BCP/Pre-C region mutations and risk of hepatocellular carcinoma in Guangxi Zhuang Autonomous Region].
    Zheng D, Deng W, Huang T, Li X, Li Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jul 15; 36(7):725-9. PubMed ID: 26564702
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.